Does KETOPROFEN Cause Mobility decreased? 12 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Mobility decreased have been filed in association with KETOPROFEN (Orudis). This represents 0.2% of all adverse event reports for KETOPROFEN.
12
Reports of Mobility decreased with KETOPROFEN
0.2%
of all KETOPROFEN reports
8
Deaths
7
Hospitalizations
How Dangerous Is Mobility decreased From KETOPROFEN?
Of the 12 reports, 8 (66.7%) resulted in death, 7 (58.3%) required hospitalization, and 2 (16.7%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KETOPROFEN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does KETOPROFEN Cause?
Pain (595)
Headache (574)
Hypersensitivity (556)
Erythema (546)
Acute kidney injury (517)
Hyperhidrosis (516)
Hepatic enzyme increased (508)
Asthma (507)
Rheumatoid arthritis (493)
Immunodeficiency (492)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which KETOPROFEN Alternatives Have Lower Mobility decreased Risk?
KETOPROFEN vs KETOPROFEN LYSINE
KETOPROFEN vs KETOROLAC TROMETHAMINE
KETOPROFEN vs KETOROLAC\KETOROLAC TROMETHAMINE
KETOPROFEN vs KETOTIFEN
KETOPROFEN vs KLONOPIN